|
Lewis Parker serves as a Strategic Advisor to the Company. Mr. Parker has been a director of the Company since July of 2004. Mr. Parker is also a member of the Board of Directors of DjOrthopedics (NYSE DJO), where he has served since 2003. Until its sale to Biomet in June 2004, he was a member of the Board of Directors of Interpore International (NASDAQ BONZ). From 2000 to 2001, he was a Director and Chief Financial Officer of American OsteoMedix. Mr. Parker began his experience in the orthopedic business in 1991 when he joined Kirschner Medical Corporation (KMDC) as its Senior Vice President and Chief Financial Officer. Later he was named President for all of Kirschner's orthopedic operations. Kirschner was sold to Biomet, Inc. in 1994. Prior to Kirschner, Mr. Parker was President and CEO of ProScience Corporation, a company he founded to engage in the application of high technology biology to veterinary diagnostics. From 1976 to 1987 he served as a Vice President of Hazleton Laboratories Corporation (HLC) where he began as Chief Financial Officer and later became President of the American laboratory subsidiary. Mr. Parker is currently a principal in Lochinvar, LLC, an organization engaged in turn around consulting, and in Parkwood, LLC, a venture investing firm. He holds a BS degree in engineering from Lehigh University and an MBA in Finance from the Wharton School at the University of Pennsylvania. | 